Literature DB >> 18624908

Transregulation of leukemia inhibitory [corrected] factor receptor expression and function by growth factors in neuroblastoma cells.

Martha D Port1, George S Laszlo, Neil M Nathanson.   

Abstract

The cytokines that signal through the leukemia inhibitory factor (LIF) receptor are members of the neuropoietic cytokine family and have varied and numerous roles in the nervous system. In this report, we have determined the effects of growth factor stimulation on LIF receptor (LIFR) expression and signal transduction in the human neuroblastoma cell line NBFL. We show here that stimulation of NBFL cells with either epidermal growth factor or fibroblast growth factor decreases the level of LIFR in an extracellular signal-regulated kinase (Erk)1/2-dependent manner and that this down-regulation is due to an increase in the apparent rate of lysosomal LIFR degradation. Growth factor-induced decreases in LIFR level inhibit both LIF-stimulated phosphorylation of signal transducers and activators of transcription 3 and LIFR-mediated gene induction. We also show that Ser1044 of LIFR, which we have previously shown to be phosphorylated by Erk1/2, is required for the inhibitory effects of growth factors. Neurons are exposed to varying combinations and concentrations of growth factors and cytokines that influence their growth, development, differentiation, and repair in vivo. These findings demonstrate that LIFR expression and signaling in neuroblastoma cells can be regulated by growth factors that are potent activators of the mitogen-activated protein kinase pathway, and thus illustrate a fundamental mechanism that underlies crosstalk between receptor tyrosine kinase and neuropoietic cytokine signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624908      PMCID: PMC2615047          DOI: 10.1111/j.1471-4159.2008.05535.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  41 in total

1.  Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function.

Authors:  Bettina Holtmann; Stefan Wiese; Mohtashem Samsam; Katja Grohmann; Diane Pennica; Rudolf Martini; Michael Sendtner
Journal:  J Neurosci       Date:  2005-02-16       Impact factor: 6.167

Review 2.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Transforming growth factor-beta and ciliary neurotrophic factor synergistically induce vasoactive intestinal peptide gene expression through the cooperation of Smad, STAT, and AP-1 sites.

Authors:  R L Pitts; S Wang; E A Jones; A J Symes
Journal:  J Biol Chem       Date:  2001-03-20       Impact factor: 5.157

4.  Protein phosphatase type 2A, PP2A, is involved in degradation of gp130.

Authors:  Shinya Mitsuhashi; Hiroshi Shima; Nobuhiro Tanuma; Sumie Sasa; Kazunori Onoe; Makoto Ubukata; Kunimi Kikuchi
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  Cytokines and implantation.

Authors:  A Sharkey
Journal:  Rev Reprod       Date:  1998-01

6.  Calmodulin-dependent protein kinases phosphorylate gp130 at the serine-based dileucine internalization motif.

Authors:  Robin M Gibson; George S Laszlo; Neil M Nathanson
Journal:  Biochim Biophys Acta       Date:  2005-08-01

Review 7.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

8.  Leukemia inhibitory factor and NGF regulate signal transducers and activators of transcription activation in sympathetic ganglia: convergence of cytokine- and neurotrophin-signaling pathways.

Authors:  P Rajan; T Gearan; J S Fink
Journal:  Brain Res       Date:  1998-08-17       Impact factor: 3.252

9.  Ciliary neurotrophic factor induces down-regulation of its receptor and desensitization of signal transduction pathways in vivo: non-equivalence with pharmacological activity.

Authors:  P S DiStefano; T G Boulton; J L Stark; Y Zhu; K M Adryan; T E Ryan; R M Lindsay
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

10.  Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine.

Authors:  A M Shadiack; S A Vaccariello; Y Sun; R E Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  3 in total

1.  Regulation of neurokine receptor signaling and trafficking.

Authors:  Neil M Nathanson
Journal:  Neurochem Int       Date:  2012-01-25       Impact factor: 3.921

2.  Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.

Authors:  Alexandra E Oxford; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  J Neurol Neuromedicine       Date:  2016

Review 3.  Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology.

Authors:  Dawn Mikelonis; Cheryl L Jorcyk; Ken Tawara; Julia Thom Oxford
Journal:  Orphanet J Rare Dis       Date:  2014-03-12       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.